aTyr Pharma | LIFE - Trade Debtors


aTyr Pharma reported $296.74M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Alterity Therapeutics Limited AUD 4.57M 1.42M Dec/2025
Ardelyx USD 71.85M 4.76M Dec/2025
aTyr Pharma USD 296.74M 295.7M Dec/2025
Biogen USD 1.79B 76.6M Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Cipla INR 62.19B 12.42B Mar/2026
Clal Biotechnology ILS 3.75M 186K Dec/2022
Compugen USD 2.38M 448K Dec/2025
CSL USD 4.32B 1.35B Dec/2025
Curis USD 2.55M 400K Jun/2024
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Grifols EUR 1B 285.88M Dec/2025
Lakefront Biotherapeutics EUR 54.03M 145.72M Mar/2026
Novartis USD 9.6B 2.69B Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
United Therapeutics USD 312M 38.2M Mar/2026
Xoma USD 14.78M 4.96M Jun/2024